Literature DB >> 31401993

Time to acknowledge, address, and take action against bronchiectasis.

Sanjay H Chotirmall1, Pamela J McShane2.   

Abstract

Mesh:

Year:  2019        PMID: 31401993     DOI: 10.1016/S2214-109X(19)30311-0

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  4 in total

1.  Integrative microbiomics in bronchiectasis exacerbations.

Authors:  Micheál Mac Aogáin; Jayanth Kumar Narayana; Pei Yee Tiew; Nur A'tikah Binte Mohamed Ali; Valerie Fei Lee Yong; Tavleen Kaur Jaggi; Albert Yick Hou Lim; Holly R Keir; Alison J Dicker; Kai Xian Thng; Akina Tsang; Fransiskus Xaverius Ivan; Mau Ern Poh; Martina Oriano; Stefano Aliberti; Francesco Blasi; Teck Boon Low; Thun How Ong; Brian Oliver; Yan Hui Giam; Augustine Tee; Mariko Siyue Koh; John Arputhan Abisheganaden; Krasimira Tsaneva-Atanasova; James D Chalmers; Sanjay H Chotirmall
Journal:  Nat Med       Date:  2021-04-05       Impact factor: 53.440

Review 2.  Respiratory Mycoses in COPD and Bronchiectasis.

Authors:  Pei Yee Tiew; Micheál Mac Aogáin; Soo Kai Ter; Stefano Aliberti; James D Chalmers; Sanjay H Chotirmall
Journal:  Mycopathologia       Date:  2021-03-11       Impact factor: 2.574

3.  Utility of a personalised Bronchiectasis Action Management Plan (BAMP) for children with bronchiectasis: protocol for a multicentre, double-blind parallel, superiority randomised controlled trial.

Authors:  Julie M Marchant; Anne B Chang; Kobi L Schutz; Lesley Versteegh; Anne Cook; Jack Roberts; Peter S Morris; Stephanie T Yerkovich; Gabrielle B McCallum
Journal:  BMJ Open       Date:  2021-12-22       Impact factor: 2.692

4.  "Can't Stop the Feeling": Symptoms as the Key to Trial Success in Bronchiectasis?

Authors:  Pierre-Régis Burgel; Sanjay H Chotirmall
Journal:  Am J Respir Crit Care Med       Date:  2020-06-15       Impact factor: 21.405

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.